FDA/CDC

Device approved to treat PDA in premature infants


 

The Food and Drug Administration has approved the Amplatzer Piccolo Occluder to treat patent ductus arteriosus (PDA) in premature infants weighing as little as 2 pounds.

FDA icon

PDA is a life-threatening opening between two blood vessels leading from the heart and commonly occurs in premature infants, with about one in five infants born prematurely having a hemodynamically significant PDA. The Amplatzer Piccolo Occluder is a self-expanding, wire mesh device that is minimally invasive and is the first device approved for use in very-low-birth-weight infants.

FDA approval was based on results of the ADO II AS trial, which evaluated the device in 50 patients with PDA who were older than 3 days. In addition, the safety and efficacy of the Amplatzer Piccolo Occluder was supported by a continued access protocol involving 150 more patients.

“This approval is a potentially life-saving advance for the very smallest premature infants that will help us treat these delicate babies who might otherwise not be able to survive,” said Evan Zahn, MD, principal investigator of ADO II AS and director of the congenital heart program at Cedars-Sinai’s Smidt Heart Institute in Los Angeles.

Find the full press release on the Abbott website.

Recommended Reading

Children born from ART at increased risk of developing arterial hypertension
MDedge Cardiology
CKD children need office blood pressures below the 75th percentile
MDedge Cardiology
Fever, intestinal symptoms may delay diagnosis of Kawasaki disease in children
MDedge Cardiology
Children with poor cardiorespiratory fitness have a higher risk of type 2 diabetes and cardiovascular disease
MDedge Cardiology
ADA releases guidelines for type 2 diabetes in children, youth
MDedge Cardiology
Under Trump, number of uninsured kids rose for first time this decade
MDedge Cardiology
Obesity meds used by just over half of pediatric obesity programs
MDedge Cardiology
BMI compares favorably with body scanning for ID of cardiometabolic traits
MDedge Cardiology
‘Payoff will be great’ if we can conquer childhood obesity, expert says
MDedge Cardiology
Carbs vs. fats for CVD
MDedge Cardiology